Z
5.17
-0.23 (-4.29%)
Penutupan Terdahulu | 5.40 |
Buka | 5.33 |
Jumlah Dagangan | 204,038 |
Purata Dagangan (3B) | 200,941 |
Modal Pasaran | 244,947,200 |
Harga / Pendapatan (P/E TTM) | 86.14 |
Harga / Jualan (P/S) | 9.74 |
Harga / Buku (P/B) | 6.59 |
Julat 52 Minggu |
Margin Keuntungan | 10.69% |
Margin Operasi (TTM) | 15.70% |
EPS Cair (TTM) | 0.060 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -18.70% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -55.30% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 24.98% |
Nisbah Semasa (MRQ) | 1.38 |
Aliran Tunai Operasi (OCF TTM) | 54.93 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.93 M |
Pulangan Atas Aset (ROA TTM) | 3.82% |
Pulangan Atas Ekuiti (ROE TTM) | 7.15% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
Stok | Zhengye Biotechnology Holding L | - | - |
AISkor Stockmoo
1.0
Konsensus Penganalisis | 0.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 1.0 |
Purata Bergerak Teknikal | 1.0 |
Osilator Teknikal | 2.0 |
Purata | 1.00 |
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - Specialty & Generic |
% Dimiliki oleh Orang Dalam | 91.64% |
% Dimiliki oleh Institusi | 0.01% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
14 Jan 2025 | Pengumuman | Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option |
08 Jan 2025 | Pengumuman | Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |